Kantonsspital St.Gallen
login

I6T-MC-AMBG

Stephan Brand, Michael Sulz, Claudia Krieger Grübel & Jolijn Smolders

abstract A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 2
   
type of project clinical studies
status ongoing - recruiting phase
start of project 2018
end of project 2021
responsible person Prof. Dr. Stephan Brand